European agency begins fast-track study of experimental Covid treatment

The European Medicines Agency (AP Photo/Peter Dejong, FILE)

The European Medicines Agency says it has begun an accelerated authorisation process for an experimental coronavirus treatment made by GlaxoSmithKline and Vir BioTechnology.

The EU drug regulator said it had started a rolling review of sotrovimab, based on early results from an ongoing study into whether the treatment can prevent hospital admission or death in people who do not yet have severe Covid-19.